Aβ aggregation-IN-1

Aβ aggregation-IN-1 (Compound 1b) is a small molecule inhibitor that targets amyloid-beta aggregation and disaggregation with IC50 values of 3.92 μM and 7.19 μM, respectively. It demonstrates neuroprotective properties in vitro by reducing oxidative stress markers, elevating glutathione, and inhibiting caspase-3 activity, making it a useful research tool for Alzheimer's disease pathology studies.